cbdMD IncYCBD
Price$0.45

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $20.9M+5.1% YoYTTM through 30 Jun 2026
Net Income -$2.9MTTM through 30 Jun 2026
Free Cash Flow -$2.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin58.0%
EBITDA Margin-9.5%
Operating Margin-14.3%
Net Margin-13.8%

Returns

-35.2%ROE
-22.0%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.80x
Net Debt-$2.6Mnet cash position
Cash & Equivalents$2.1M

Quality Metrics

Altman Z-Score-17.40
Piotroski F-Score2 / 9
FCF Margin-11.5%
Rule of 40-5.7
Earnings-Beat Rate33.3%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $19.2M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-0.51

Dividend

No dividend

Capital Allocation

Capex Intensity0.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.